MAB welcomes Pangaea Oncology

MAB today welcomed PANGAEA ONCOLOGY to its growth companies segment. It becomes the twenty third company to join MAB this year.

Álvaro Castro Martínez, Supervision Manager and MAB Member of the Board, stated: "the listing of Pangaea Oncology a new company in the Health sector, shows once more the versatility of MAB as a source of financing. 2016 has been an excellent year for MAB market with the listing of 23 new companies which have raised around €300 million in financing”.

Impulsa Capital is acting as Registered Adviser of the company. Bankinter Securities will act as the Liquidity Provider.

To access and download the photos of the listing on MAB, available on Flickr, please follow this link:


If an issue occurs, the message "TRADING" will change to "MARKET ISSUE" to reflect that a market event has occurred. By clicking on the Issue of the published alert it will be possible to access the information and intraday updates associated with this incident, which will be published immediately.

Note: BME will use its discretion to assign the severity of an incident